| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
31,350,000 |
| Market
Cap: |
16.03(M) |
| Last
Volume: |
15,038 |
Avg
Vol: |
14,996 |
| 52
Week Range: |
$0.2127 - $0.648 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
9,750 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,584 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
60,000 |
60,000 |
60,000 |
60,000 |
| Total Sell Value |
$950,777 |
$950,777 |
$950,777 |
$950,777 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
3 |
3 |
3 |
3 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Desouza Errol B |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,129 |
14,627 |
|
- |
|
| Ling Geoffrey M.d. |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,703 |
6,635 |
|
- |
|
| Williams Eddie |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,011 |
14,567 |
|
- |
|
| Lawlor Augustine |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,934 |
20,542 |
|
- |
|
| Ling Geoffrey M.d. |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,932 |
4,932 |
|
- |
|
| Desouza Errol B |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,860 |
12,498 |
|
- |
|
| Hunt Andrea |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,673 |
6,799 |
|
- |
|
| Tetlow Sharon |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,932 |
1,932 |
|
- |
|
| Williams Eddie |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,717 |
13,556 |
|
- |
|
| Levy Howard |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
B |
$4.05 |
$10,132 |
D/D |
2,500 |
2,500 |
2.74 |
51% |
|
| Richard John P |
Director |
– • – |
2020-03-13 |
4 |
B |
$3.98 |
$9,950 |
D/D |
2,500 |
3,716 |
2.39 |
38% |
|
| Usman Nassim |
President & CEO |
• • – |
2020-03-13 |
4 |
B |
$3.91 |
$15,647 |
D/D |
4,000 |
11,010 |
2.81 |
38% |
|
| Cai Veronica |
Controller |
• – – |
2020-03-13 |
4 |
B |
$4.11 |
$8,220 |
D/D |
2,000 |
7,353 |
2.74 |
38% |
|
| Williams Eddie |
Director |
– • – |
2020-03-04 |
4 |
B |
$5.78 |
$11,560 |
D/D |
2,000 |
10,839 |
2.39 |
-7% |
|
| Lawlor Augustine |
Director |
– • – |
2020-02-25 |
4 |
S |
$6.10 |
$423,506 |
I/I |
(69,401) |
0 |
|
5% |
|
| Ling Geoffrey M.d. |
Director |
– • – |
2020-02-25 |
4 |
B |
$6.23 |
$18,692 |
D/D |
3,000 |
3,000 |
2.39 |
-5% |
|
| Usman Nassim |
President & CEO |
• • – |
2020-02-10 |
4 |
A |
$6.23 |
$2,679 |
D/D |
430 |
7,010 |
|
- |
|
| Cai Veronica |
Controller |
• – – |
2020-02-10 |
4 |
A |
$6.23 |
$10,454 |
D/D |
1,678 |
5,353 |
|
- |
|
| Levy Howard |
Chief Medical Officer |
• – – |
2020-02-10 |
4 |
A |
$6.23 |
$8,460 |
D/D |
1,358 |
1,358 |
|
- |
|
| Williams Eddie |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,743 |
8,839 |
|
- |
|
| Hunt Andrea |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
5,126 |
|
- |
|
| Desouza Errol B |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,835 |
9,638 |
|
- |
|
| Lawlor Augustine |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,166 |
15,608 |
|
- |
|
| Hunt Andrea |
Director |
– • – |
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,489 |
4,053 |
|
- |
|
| Desouza Errol B |
Director |
– • – |
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,545 |
7,803 |
|
- |
|
141 Records found
|
|
Page 3 of 6 |
|
|
